COMPOSITION OF HIGH DENSITY LIPOPROTEIN SUBCLASSES
高密度脂蛋白亚类的组成
基本信息
- 批准号:7601817
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-30 至 2008-05-31
- 项目状态:已结题
- 来源:
- 关键词:Age-YearsAntiatherogenicAntibodiesAntibody SpecificityApolipoprotein EAtherosclerosisBlindnessCellsCholesterolComputer Retrieval of Information on Scientific Projects DatabaseCoronary ArteriosclerosisFundingGrantHigh Density LipoproteinsHumanIndiumIndividualInstitutionLaboratoriesLipidsLipoproteinsMacular degenerationMass Spectrum AnalysisMediatingMetabolicMetabolismMethodsMolecularPlasmaPlayProtease InhibitorProteinsResearchResearch PersonnelResourcesRetinalRoleSourceStructure of retinal pigment epitheliumTransfer FactorTransferaseUnited States National Institutes of HealthWestern Blottinghepatic lipaseinsightlipid metabolismlipid transportparticlephosphatidylcholine transfer protein
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Our studies of lipoprotein metabolism, in particular, the high density lipoproteins (HDL) offer unique insights into lipid metabolism and transport that will be of value in understanding atherosclerosis at a molecular level. Methods developed in our laboratory have allowed us to document previously unreported molecular subspecies of HDL, each of which may play a specific antiatherogenic role associated with HDL. HDL subspecies purified from plasmas of normo- and dyslipidemic subjects reveal a variety of proteins. To date we have identified fifty-three candidate proteins that associate with discrete HDL particles. Among these , we have also discovered a new protein, designated apoL-1, that is associated with two discrete HDL species. While protein compositions of some HDL subspecies have been identified by Western blotting, we seek to obtain unequivocal characterization by mass spectroscopy especially in cases were our antibodies produce questionable identities. This frequently results from poor antibody specificity and recognition. Mass spectroscopic identification is of most benefit for the identification of proteins for which we have no specific antibodies, for proteins of low concentration, and for proteins which are not generally considered to associate with HDL. Our understanding of the HDL protein components consisting of lipid transfer factors such as cholesterol transfer protein, lecithin:cholesterol transferase, phosholipid transfer protein, hepatic lipase, plasma protease inhibitors, apoE, apoAIV, and apoL is paramount to our ability to understand the metabolic function of HDL-mediated protection in coronary artery disease.
We have now begun to study the role of lipid transport in the retinal pigment epithelial cells, because they are key elements in human macular degeneration, the major cause of blindness in individuals over fifty years of age. This involves the identification of proteins expressed by the retinal cells, using mass spectrometry.
该子项目是利用该技术的众多研究子项目之一
资源由 NIH/NCRR 资助的中心拨款提供。子项目和
研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金,
因此可以在其他 CRISP 条目中表示。列出的机构是
对于中心来说,它不一定是研究者的机构。
我们对脂蛋白代谢,特别是高密度脂蛋白(HDL)的研究为脂质代谢和运输提供了独特的见解,这对于在分子水平上理解动脉粥样硬化具有重要价值。我们实验室开发的方法使我们能够记录以前未报道的 HDL 分子亚种,每种分子亚种都可能发挥与 HDL 相关的特定抗动脉粥样硬化作用。 从血脂正常和血脂异常受试者的血浆中纯化的 HDL 亚种揭示了多种蛋白质。迄今为止,我们已经鉴定了 53 种与离散 HDL 颗粒相关的候选蛋白质。其中,我们还发现了一种新的蛋白质,称为 apoL-1,它与两种不同的 HDL 物种相关。虽然一些 HDL 亚种的蛋白质组成已通过蛋白质印迹法鉴定,但我们寻求通过质谱法获得明确的表征,特别是在我们的抗体产生可疑身份的情况下。这通常是由于抗体特异性和识别能力差造成的。质谱鉴定最有利于鉴定我们没有特异性抗体的蛋白质、低浓度的蛋白质以及通常被认为与 HDL 不相关的蛋白质。我们对由脂质转移因子(如胆固醇转移蛋白、卵磷脂:胆固醇转移酶、磷脂转移蛋白、肝脂肪酶、血浆蛋白酶抑制剂、apoE、apoAIV 和 apoL)组成的 HDL 蛋白成分的了解,对于我们了解 HDL 介导的冠状动脉疾病保护的代谢功能至关重要。
我们现在开始研究视网膜色素上皮细胞中脂质运输的作用,因为它们是人类黄斑变性的关键因素,黄斑变性是五十岁以上个体失明的主要原因。 这涉及使用质谱法鉴定视网膜细胞表达的蛋白质。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN P KANE其他文献
JOHN P KANE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN P KANE', 18)}}的其他基金
ANALYSIS OF THE PROTEIN COMPOSITION OF ARTERIOSCLEROTIC PLAQUES
动脉硬化斑块的蛋白质组成分析
- 批准号:
8363852 - 财政年份:2011
- 资助金额:
-- - 项目类别:
相似海外基金
Antiatherogenic effects of neutrophil alpha defensins
中性粒细胞α防御素的抗动脉粥样硬化作用
- 批准号:
8360808 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Antiatherogenic effects of neutrophil alpha defensins
中性粒细胞α防御素的抗动脉粥样硬化作用
- 批准号:
8505376 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Antiatherogenic effects of high density lipoprotein and sphingosine 1-phosphate
高密度脂蛋白和1-磷酸鞘氨醇的抗动脉粥样硬化作用
- 批准号:
18590973 - 财政年份:2006
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of the mechanisms for antiatherogenic effect of bone marrow AT2 receptor by using gene-targeted mice
基因靶向小鼠分析骨髓AT2受体抗动脉粥样硬化作用机制
- 批准号:
17590760 - 财政年份:2005
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Antiatherogenic Properties of tert-Butylhydroquinone
叔丁基氢醌的抗动脉粥样硬化特性
- 批准号:
6786512 - 财政年份:2004
- 资助金额:
-- - 项目类别:
Antiatherogenic action of estrogen through inhibition of pathological proliferation in vascular smooth muscle sells
雌激素通过抑制血管平滑肌病理性增殖发挥抗动脉粥样硬化作用
- 批准号:
14370523 - 财政年份:2002
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




